Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D06ERA
|
||||
| Former ID |
DNC007909
|
||||
| Drug Name |
AcNPY(25-36)
|
||||
| Indication | Discovery agent | Investigative | [528484] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C76H119N27O18
|
||||
| Canonical SMILES |
CCC(C)C1C(=O)NC(CCC(=O)NCCCCC(C(=O)NC(C(=O)NC(C(=O)N1)C<br />C(C)C)CC(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CC3=CN=CN<br />3)NC(=O)C(CCCNC(=N)N)NC(=O)C)C(=O)NC(CCCNC(=N)N)C(=O)NC<br />(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC4=CC=C(C=C4)O)C(<br />=O)N
|
||||
| InChI |
1S/C76H119N27O18/c1-6-40(4)61-73(121)97-52(68(116)93-49(14-10-30-89-75(82)83)64(112)96-51(24-26-58(77)107)67(115)94-50(15-11-31-90-76(84)85)65(113)98-53(62(79)110)33-42-16-20-45(105)21-17-42)25-27-60(109)87-28-8-7-12-48(66(114)102-57(36-59(78)108)71(119)99-54(32-39(2)3)72(120)103-61)95-69(117)55(34-43-18-22-46(106)23-19-43)100-70(118)56(35-44-37-86-38-91-44)101-63(111)47(92-41(5)104)13-9-29-88-74(80)81/h16-23,37-40,47-57,61,105-106H,6-15,24-36H2,1-5H3,(H2,77,107)(H2,78,108)(H2,79,110)(H,86,91)(H,87,109)(H,92,104)(H,93,116)(H,94,115)(H,95,117)(H,96,112)(H,97,121)(H,98,113)(H,99,119)(H,100,118)(H,101,111)(H,102,114)(H,103,120)(H4,80,81,88)(H4,82,83,89)(H4,84,85,90)/t40-,47+,48+,49+,50+,51+,52+,53+,54+,55+,56+,57+,61+/m1/s1
|
||||
| InChIKey |
RDOFKMDVEDQFIJ-WQSAXVMWSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Neuropeptide Y receptor type 2 | Target Info | Inhibitor | [528484] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.